| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
David S. Ege last filed a Form 4 in August 2024, as See Remarks at MCRB. David S. Ege's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, David S. Ege's trades have earned a strong insider score of 80/100 across 6 rated trades. Over a 12-month horizon, all 6 of those trades were profitable, with an average 12-month return of +50.0%.
At the last filing, the largest reported position was 77,575 shares of MCRB. The MCRB filings lean toward selling, a net 23,344 shares.
David S. Ege has 10 Form 4 filings on record from October 2020 to August 2024, all as Seres Therapeutics (MCRB), 2020–2024.
The 21 reported transactions were 8 option or other derivative awards, 6 open-market sales, 4 option exercises and 3 stock awards.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $89K.
The largest open-market sale was 5,012 shares of MCRB at an average $7.93 on October 31, 2022, about $40K. Twelve months later MCRB was down 83%.
4 of the 5 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 1,128 | $0.84 | $947.52 | -1.4% | -32.7% | -5.1% | |
| May 15, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 1,090 | $0.94 | $1,024.60 | -1.4% | -13.6% | -61.3% | |
| Feb 16, 2024 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 5,010 | $1.08 | $5,410.80 | -6.4% | -12.0% | -20.7% | |
| Oct 30, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sale+OE10b5-1 | 4,066 | $1.35 | $5,489.10 | -5.7% | -13.8% | -46.8% | |
| Apr 28, 2023 | MCRB Seres Therapeutics, Inc. | See Remarks | Sell | 7,038 | $5.19 | $36,527.22 | -10.5% | -9.3% | -83.1% | |
| Oct 31, 2022 | MCRB Seres Therapeutics, Inc. | See Remarks | Sell | 5,012 | $7.93 | $39,745.16 | -9.7% | -38.4% | -82.7% |